STATE STREET CORP - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 51 filers reported holding INOZYME PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q2 2024$4,460,152
-33.9%
1,000,034
+13.6%
0.00%
Q1 2024$6,745,695
+112.1%
880,639
+18.0%
0.00%
Q4 2023$3,180,231
+20.5%
746,533
+18.8%
0.00%
Q3 2023$2,639,057
-15.5%
628,347
+12.0%
0.00%
Q2 2023$3,123,890
+456.0%
560,842
+472.0%
0.00%
Q1 2023$561,855
+250.4%
98,055
-35.8%
0.00%
Q4 2022$160,346
-21.8%
152,710
+100.0%
0.00%
Q3 2022$205,000
-12.4%
76,355
+55.7%
0.00%
Q2 2022$234,000
-69.7%
49,055
-74.0%
0.00%
Q1 2022$773,000
-39.4%
189,005
+1.0%
0.00%
Q4 2021$1,276,000
-41.5%
187,102
-0.6%
0.00%
Q3 2021$2,182,000
-24.6%
188,267
+10.8%
0.00%
Q2 2021$2,895,000
+10.6%
169,889
+28.5%
0.00%
Q1 2021$2,618,000
+7.9%
132,219
+12.5%
0.00%
Q4 2020$2,427,000
+30.8%
117,579
+66.6%
0.00%
Q3 2020$1,856,00070,5850.00%
Other shareholders
INOZYME PHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 4,494,851$34,430,55922.13%
Affinity Asset Advisors, LLC 2,642,519$20,241,6962.51%
Blue Owl Capital Holdings LP 1,270,027$9,728,4071.94%
Samsara BioCapital, LLC 1,562,500$11,968,7501.85%
Sofinnova Investments, Inc. 4,280,308$32,787,1591.83%
Exome Asset Management LLC 273,413$2,094,3441.79%
Knott David M Jr 564,549$4,3241.53%
SPHERA FUNDS MANAGEMENT LTD. 1,372,907$10,516,4681.48%
NEA Management Company, LLC 2,437,689$18,672,6981.16%
Rock Springs Capital Management LP 3,681,174$28,197,7930.72%
View complete list of INOZYME PHARMA INC shareholders